Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Why Pharma Marketing Has Never Had Its Defining Infrastructure Moment
Harshit Jain, MD, is Founder & Global CEO of Doceree. There is a meeting that I've seen happen at some point in every major pharma company. The meeting has a room full of smart, experienced marketers, slides loaded with data and dashboards…
Alnylam Pharma (ALNY) Q2 2026 Earnings Call Transcript
Thursday, July 30, 2026, at 8:30 a.m. ET Vice President of Investor Relations - Josh Brodsky Chief Executive Officer - Yvonne Greenstreet Chief Financial Officer - Jeff Poulton Chief Commercial Officer - Tolga Tanguler Chief Research and…
Sun Pharma gets Brazil nod for Semaglutide
Sun Pharmaceutical Industries has received Brazilian Health Regulatory Agency ANVISA approval to manufacture and market semaglutide injection in the Latin American country. The generic drugmaker plans to launch the product in the next few days in…
Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
This has been an active year in the mergers-and-acquisitions landscape across the biopharmaceutical industry. One of the more notable deals was Vertex Pharmaceuticals ' acquisition of Crinetics Pharmaceuticals for $10 billion in cash (the…
India tightens drug quality norms, eyes biopharma push: Pharma Secretary
The Centre has begun cracking down on pharmaceutical manufacturers that fail to meet revised quality standards, with non-compliant companies being asked to shut down unless they upgrade their facilities, said Manoj Joshi, Secretary, Department of…
Sun Pharma gets green signal on semaglutide in Brazil, its second export market
Sun Pharmaceutical Industries has received approval from the Brazilian Health Regulatory Agency – ANVISA, to manufacture and market semaglutide injection in Brazil for the treatment of adults with inadequately controlled type 2 diabetes…
Ajanta Pharma Q1 results: PAT rises 31% to ₹334 cr
Ajanta Pharma Ltd on Thursday reported a 31 per cent rise in profit after tax to ₹334 crore for the first quarter ended June 30. The company had posted a profit after tax (PAT) of ₹255 crore in the corresponding period of the last…
Urogen Pharma (URGN) to Announce Quarterly Earnings on Thursday
Urogen Pharma (NASDAQ:URGN - Get Free Report) is expected to be releasing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect the company to announce earnings of ($0.2650) per share and revenue of $63.5460 million…
Reversing Alzheimer's - The Forgotten Causes and Cures Big Pharma Buried
It's not the mind fading; it's the neurons refusing to speak under the weight of blocked blood, stale sleep, and chemical noise. Remove the interference, and even the quietest thoughts begin to whisper again. If you're being told you can get all…
Quality Reforms, Biopharma Ecosystem Top Priority to Keep India as 'Pharmacy of World': Pharma Secy Manoj Joshi
From implementation of revised schedule M norms to tighter regulatory oversight and efforts to improve manufacturing, Manoj Joshi, Secretary, Department of Pharmaceuticals, in an interview with businessline covered the government's roadmap to…
Athira Pharma (NASDAQ:LONA) Stock Rating Upgraded by Citizens Jmp
Athira Pharma (NASDAQ:LONA - Get Free Report) was upgraded by Citizens Jmp from a 'market perform' rating to an 'outperform' rating in a research note issued on Thursday, Marketbeat Ratings reports. The firm presently has a $18.00 price target on…
Torrent Pharma FYQ1 PAT rises 3.3% as JB integration costs & higher finance charges weigh on earnings
Torrent Pharmaceuticals, the flagship company of Gujarat-based Torrent Group, reported a modest 3.3 per cent year-on-year increase in consolidated net profit for the first quarter of FY27 as higher finance costs, depreciation and one-time…
Ascendis Pharma A/S $ASND Stock Holdings Reduced by Tri Locum Partners LP
Tri Locum Partners LP reduced its stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 3.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 255,332…
Janus Henderson Group PLC Has $978.61 Million Stock Holdings in BridgeBio Pharma, Inc. $BBIO
Janus Henderson Group PLC grew its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 19.8% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund…
Bajaj Finance Q1 Profit Surge Boosts Indian Markets, FII Inflows Continue
Indian stock market benchmarks Sensex and Nifty traded higher in early deals, propelled by a robust 6 per cent surge in Bajaj Finance shares following its impressive Q1 FY27 earnings, alongside sustained foreign fund inflows and declining crude oil…
Receive a Daily briefing on Pharma Industry News
Get Started